Sancuso launches in the EU for Nausea
ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co., Ltd., announced that it has commenced the EU roll-out of its transdermal patch, Sancuso, for the prevention of Chemotherapy-Induced Nausea and Vomiting.
Sancuso has now been launched by ProStrakan�s own sales teams in the UK, Germany and the Netherlands, with additional EU countries planned for 2014. The launches follow the approval of Sancuso by the European Medicines Evaluation Agency (EMEA) in 2012. Sancuso was first launched in the US in 2008 and has been successfully marketed there by ProStrakan since then.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
2 mins